| scholarly article | Q13442814 |
| P50 | author | Albrecht Reichle | Q59819086 |
| Pan Pantziarka | Q85394483 | ||
| P2093 | author name string | Lina Ghibelli | |
| P2860 | cites work | An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids | Q57794088 |
| Lowering Etoposide Doses Shifts Cell Demise From Caspase-Dependent to Differentiation and Caspase-3-Independent Apoptosis via DNA Damage Response, Inducing AML Culture Extinction | Q59335637 | ||
| Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumors | Q60305730 | ||
| Apoptosis in breast cancer and its relationship to clinicopathological characteristics and prognosis | Q78107718 | ||
| Tumor biology: with a little help from my dying friends | Q86858860 | ||
| The evolution of the cancer niche during multistage carcinogenesis | Q86940390 | ||
| Mutant p53-Expressing Cells Undergo Necroptosis via Cell Competition with the Neighboring Normal Epithelial Cells | Q89291565 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Translational implications of tumor heterogeneity | Q26822823 | ||
| Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis | Q26858839 | ||
| How cell death shapes cancer | Q27021441 | ||
| The Repurposing Drugs in Oncology (ReDO) Project. | Q33893949 | ||
| Preparing the "soil": the premetastatic niche | Q34187595 | ||
| Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in-vivo | Q34479321 | ||
| Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche | Q35717532 | ||
| Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort | Q36070763 | ||
| MYC, Cell Competition, and Cell Death in Cancer: The Inseparable Triad | Q36350155 | ||
| Primary extraosseous Ewing sarcoma of the lung in children | Q36791086 | ||
| Environment-mediated drug resistance: a major contributor to minimal residual disease | Q37582773 | ||
| Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues | Q37815130 | ||
| The Sound of Silence: Signaling by Apoptotic Cells | Q38393445 | ||
| Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future | Q38758819 | ||
| The cell fate: senescence or quiescence | Q38936424 | ||
| Emergent properties of a computational model of tumour growth | Q39603486 | ||
| Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer | Q40279124 | ||
| Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia | Q40640442 | ||
| Gompertzian growth pattern correlated with phenotypic organization of colon carcinoma, malignant glioma and non-small cell lung carcinoma cell lines. | Q40656837 | ||
| Proliferation/quiescence: the controversial "aller-retour". | Q41915205 | ||
| Systems biology: a therapeutic target for tumor therapy | Q41961938 | ||
| A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition | Q42150466 | ||
| Human Cancer Cells Signal Their Competitive Fitness Through MYC Activity | Q42282618 | ||
| Apoptosis drives cancer cells proliferate and metastasize. | Q42914191 | ||
| Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. | Q47144193 | ||
| Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy? | Q48632194 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | computational model | Q1122506 |
| Drug repurposing | Q57001948 | ||
| P304 | page(s) | 287 | |
| P577 | publication date | 2019-03-26 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | A Computational Model of Tumor Growth and Anakoinosis | |
| P478 | volume | 10 |
| Q92541944 | Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis Induction | cites work | P2860 |
Search more.